Publication | Closed Access

A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design

VaccinationEngineeringVaccine DevelopmentHeterologous Lipoprotein ImmunogenImmunologySynthetic BiologyStrain SelectionHigh YieldVaccine DesignPolyvalent VaccineMedicineVaccine ResearchSynthetic ImmunologyBiomolecular EngineeringEgg-based Vaccine Production